Moscatilin induces apoptosis and mitotic catastrophe in human esophageal cancer cells

Journal of Medicinal Food

Volumn 16, Issue 10, 2013, Pages 869-877

  Chen, Chien An ^a,b,c   Chen, Chien Chih ^d   Shen, Chien Chang ^e   Chang, Hen Hong ^c,f   Chen, Yu Jen ^g,h,i  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b Graduate Institute of Clinical Medicine   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d HUNGKUANG UNIVERSITY   (Taiwan)

^e NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^f CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^g MACKAY MEMORIAL HOSPITAL   (Taiwan)

^h NATIONAL YANG MING UNIVERSITY   (Taiwan)

ⁱ CHINESE CULTURE UNIVERSITY   (Taiwan)

Author keywords

esophageal cancer; moscatilin; polyploidization; sub G1

Indexed keywords

ANTINEOPLASTIC AGENT; BIBENZYL DERIVATIVE; CASPASE 3; CASPASE 7; CYCLIN B1; MOSCATILIN; POLO LIKE KINASE 1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE; CELL POPULATION; CHROMATIN CONDENSATION; CHROMOSOME; ENZYME ACTIVITY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; GIANT CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MICRONUCLEUS; MITOSIS; MITOSIS INDEX; MITOSIS INHIBITION; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZYL COMPOUNDS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CYCLIN B1; DENDROBIUM; DRUGS, CHINESE HERBAL; ESOPHAGEAL NEOPLASMS; HUMANS; MITOSIS;

EID: 84886073209     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.2617     Document Type: Article

References (31)

1. Newman DJ, Cragg GM: Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007;70:461-477.
2. Song JI, Kang YJ, Yong HY, Kim YC, Moon A: Denbinobin, a phenanthrene from dendrobium nobile, inhibits invasion. Oncol Rep 2012;27:813-818.
3. Chen TH, Pan SL, Guh JH, et al.: Moscatilin induces apoptosis in human colorectal cancer cells: a crucial role of c-Jun NH2- terminal protein kinase activation caused by tubulin depolymerization and DNA damage. Clin Cancer Res 2008;14:4250-4258.
4. Ho CK, Chen CC: Moscatilin from the orchid Dendrobrium loddigesii is a potential anticancer agent. Cancer Invest 2003;21: 729-736.
5. Chen CC, Wu LG, Ko FN, Teng CM: Antiplatelet aggregation principles of Dendrobium loddigesii. J Nat Prod 1994;57:1271-1274.
6. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
7. Bedenne L, Michel P, Bouche O, et al.: Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007;25: 1160-1168.
8. Kranzfelder M, Buchler P, Lange K, Friess H: Treatment options for squamous cell cancer of the esophagus: a systematic review of the literature. J Am Coll Surg 2010;210:351-359.
9. Chiarion-Sileni V, Corti L, Ruol A, et al.: Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer. Br J Cancer 2007;96:432-438.
10. Roninson IB, Broude EV, Chang BD: If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat 2001;4:303-313.
11. Okada H, Mak TW: Pathways of apoptotic and non-Apoptotic death in tumour cells. Nat Rev Cancer 2004;4:592-603.
12. Waldman T, Lengauer C, Kinzler KW, Vogelstein B: Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 1996;381:713-716.
13. Eriksson D, Lofroth PO, Johansson L, Riklund KA, Stigbrand T: Cell cycle disturbances and mitotic catastrophes in HeLa Hep2 cells following 2.5 to 10 Gy of ionizing radiation. Clin Cancer Res 2007;13:5501s-5508s.
14. Schmidt M, Bastians H: Mitotic drug targets and the development of novel anti-mitotic anticancer drugs. Drug Resist Updat 2007;10:162-181.
15. Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L: Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 1996;56:816-825.
16. Woods CM, Zhu J, McQueney PA, Bollag D, Lazarides E: Taxol-induced mitotic block triggers rapid onset of a p53- independent apoptotic pathway. Mol Med 1995;1:506-526.
17. Rieder CL, Maiato H: Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev Cell 2004;7:637-651.
18. Jordan MA, Wilson L: Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004;4:253-265.
19. Strauss SJ, Higginbottom K, Juliger S, et al.: The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines. Cancer Res 2007;67:2783-2790.
20. Hernandez-Vargas H, Palacios J, Moreno-Bueno G: Telling cells how to die: docetaxel therapy in cancer cell lines. Cell Cycle 2007;6:780-783.
21. Morse DL, Gray H, Payne CM, Gillies RJ: Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells. Mol Cancer Ther 2005;4:1495-1504.
22. Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G: Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004;23:2825-2837.
23. Blagosklonny MV, Robey R, Sheikh MS, Fojo T: Paclitaxelinduced FasL-independent apoptosis and slow (non-Apoptotic) cell death. Cancer Biol Ther 2002;1:113-117.
24. Demidenko ZN, Blagosklonny MV: Flavopiridol induces p53 via initial inhibition of Mdm2 and p21 and, independently of p53, sensitizes apoptosis-reluctant cells to tumor necrosis factor. Cancer Res 2004;64:3653-3660.
25. Vitale I, Galluzzi L, Castedo M, Kroemer G: Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol 2011;12:385-392.
26. Eom YW, Kim MA, Park SS, et al.: Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype. Oncogene 2005;24:4765-4777.
27. Ngan CY, Yamamoto H, Takagi A, et al.: Oxaliplatin induces mitotic catastrophe and apoptosis in esophageal cancer cells. Cancer Sci 2008;99:129-139.
28. van Vugt MA, van de Weerdt BC, Vader G, et al.: Polo-like kinase-1 is required for bipolar spindle formation but is dispensable for anaphase promoting complex/Cdc20 activation and initiation of cytokinesis. J Biol Chem 2004;279:36841-36854.
29. Mundt KE, Golsteyn RM, Lane HA, Nigg EA: On the regulation and function of human polo-like kinase 1 (PLK1): effects of overexpression on cell cycle progression. Biochem Biophys Res Commun 1997;239:377-385.
30. Kops GJ,Weaver BA, Cleveland DW: On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 2005;5:773-785.
31. Nitta M, Kobayashi O, Honda S, et al.: Spindle checkpoint function is required for mitotic catastrophe induced by DNAdamaging agents. Oncogene 2004;23:6548-6558.